Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Long-Term Investments (2021 - 2025)

Historic Long-Term Investments for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $433.9 million.

  • Roivant Sciences' Long-Term Investments rose 4960.25% to $433.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $433.9 million, marking a year-over-year increase of 4960.25%. This contributed to the annual value of $302.9 million for FY2025, which is 2227.46% up from last year.
  • Latest data reveals that Roivant Sciences reported Long-Term Investments of $433.9 million as of Q4 2025, which was up 4960.25% from $412.3 million recorded in Q3 2025.
  • Over the past 5 years, Roivant Sciences' Long-Term Investments peaked at $436.8 million during Q3 2021, and registered a low of $180.4 million during Q2 2021.
  • Moreover, its 5-year median value for Long-Term Investments was $293.1 million (2023), whereas its average is $299.4 million.
  • Over the last 5 years, Roivant Sciences' Long-Term Investments had its largest YoY gain of 7241.9% in 2022, and its largest YoY loss of 4353.93% in 2022.
  • Quarter analysis of 5 years shows Roivant Sciences' Long-Term Investments stood at $398.7 million in 2021, then plummeted by 31.67% to $272.5 million in 2022, then decreased by 11.94% to $239.9 million in 2023, then grew by 20.89% to $290.0 million in 2024, then soared by 49.6% to $433.9 million in 2025.
  • Its Long-Term Investments stands at $433.9 million for Q4 2025, versus $412.3 million for Q3 2025 and $283.8 million for Q2 2025.